Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
LOTUSEYE Stock Analysis
Views
Red Flags
Positive
Strong price momentum
Low Debt to Equity, not much change from last year
Company's earnings are of high quality
Negative
Expensive and at a premium to industry median P/E
Low but stable ROE
Low but stable operating margin
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Not enough talking point with neutral stance
Stock in ASM list
The stock has been places in Additional Surveillance Measure (ASM) list (LTASM - I (13)).
Snapshot
See detailed analysis
LOTUSEYE Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
LOTUSEYE Bulk, Block & Insider Trades
LOTUSEYE Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No capital change events found
Company Profile
Lotus Eye Hospital and Institute Limited is an India-based company, which is engaged in the business of healthcare activities. The Company is engaged in the field of ophthalmology (eye) and its related operations. It resolves a range of eye problems, such as refractive, cataract, cornea infections, ... Read More
Key personnel
Ms. Kavetha SundaramoorthyD
Chairman of the Board
Mr. Ramanujam Reghunathan
Chief Financial Officer
Mr. M Achuth Menon
Company Secretary, Compliance Officer
Ms. Sangeetha K. SundaramoorthyD
Managing Director, Executive Director
Dr. K.S. RamalingamD
Non-Executive Non-Independent Director
Mr. Perumalsamy MahendranD
Independent Director
Dr. S. NatesanD
Additional Non-Executive Independent Director
Mr. Karthik VeeramaniD
Additional Non-Executive Independent Director
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Lotus Eye Hospital And Institute Ltd.?
The current share price of Lotus Eye Hospital And Institute Ltd. is ₹ 112.59 as of 09 Jan 2026.
What is the PE ratio of Lotus Eye Hospital And Institute Ltd.?
The Price-to-Earnings (PE) ratio of Lotus Eye Hospital And Institute Ltd. is 347.44 as of the latest financial data.
What is the ROE and ROCE of Lotus Eye Hospital And Institute Ltd.?
Lotus Eye Hospital And Institute Ltd. has a Return on Equity (ROE) of 1.12% and a Return on Capital Employed (ROCE) of 0.73% as per the latest financial reports.
What is the market cap of Lotus Eye Hospital And Institute Ltd.?
The market capitalization of Lotus Eye Hospital And Institute Ltd. stands at ₹ 234.14 Cr.
What is the dividend yield of Lotus Eye Hospital And Institute Ltd.?
The dividend yield of Lotus Eye Hospital And Institute Ltd. is 0.00% based on the current market price.
What is the RSI of Lotus Eye Hospital And Institute Ltd.?
The Relative Strength Index (RSI) of Lotus Eye Hospital And Institute Ltd. is 39.25.
What is the FII and DII holding in Lotus Eye Hospital And Institute Ltd.?
Foreign Institutional Investors (FII) hold 0.01% and Domestic Institutional Investors (DII) hold 0.00% of Lotus Eye Hospital And Institute Ltd. shares.
What sector does Lotus Eye Hospital And Institute Ltd. belong to?
Lotus Eye Hospital And Institute Ltd. operates in the Healthcare sector.
What is the beta of Lotus Eye Hospital And Institute Ltd. stock?
The beta of Lotus Eye Hospital And Institute Ltd. stock is 0.97, indicating its volatility relative to the broader market.
